Medication info
Lamezol Capsule 20 mg (Omeprazole)

Lamezol Capsule 20 mg (Omeprazole)

Prescription medicationHard capsuleOral
Ingredient · strength
Omeprazole›20mg / 1 capsule
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
A hard capsule with an upper red-brown and a lower pink color filled with white to light brown enteric-coated granules.
Packaging
30 capsules/bottle, 100 capsules/bottle
Approval status
Active

MFDS item code 199202074 · Notified 1992.09.01

Summary

Main use
Treatment and prevention of gastroesophageal reflux and gastrointestinal disorders (e.g., ulcers and erosions); treatment of Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
◎ Adults 1) Gastric ulcer: Administer 20mg of omeprazole orally once daily. Most ulcers may heal within 4 weeks, although the healing period may vary among patients. If healing is incomplete after the initial 4 weeks of treatment, continue treatment for another 4 weeks. In patients who have not responded to other medications, administration of 40mg once daily usually results in healing within 8 weeks, although the healing period may vary among patients. Repeat treatment if the condition recurs. 2) Short-term treatment of duodenal ulcer: Administer 20mg orally once daily. Most ulcers may heal within 2 weeks, although the healing period may vary among patients. If healing is incomplete after the initial 2 weeks of treatment, continue treatment for another 2 weeks. In patients who have not responded to other medications, administration of 40mg once daily usually results in healing within 4 weeks, although the healing period may vary among patients. Repeat treatment if the condition recurs. 3) Treatment of reflux esophagitis and symptoms of gastroesophageal reflux disease (GERD) (heartburn, regurgitation, etc.): - Reflux esophagitis: Administer 20mg orally once daily. Most cases may heal within 4 weeks, although the healing period may vary among patients. If healing is incomplete after the initial 4 weeks of treatment, continue treatment for another 4 weeks. In patients who have not responded to other medications, administration of 40mg once daily usually results in healing within 8 weeks, although the healing period may vary among patients. Repeat treatment if the condition recurs. - Treatment of symptoms of gastroesophageal reflux disease (GERD) (heartburn, regurgitation, etc.): Administer 20mg orally once daily. Treatment for 2~4 weeks is generally sufficient for healing. 4) Maintenance treatment for severe reflux esophagitis and peptic ulcers that are difficult to heal: Administer 20mg orally once daily. If the condition recurs, the dose may be increased to 40mg once daily. 5) Zollinger-Ellison syndrome: The initial dose is 60mg orally once daily. Continue treatment, adjusting the dose as appropriate for each patient. More than 90% of patients respond to doses of 20 - 120mg per day. If a dose of 80mg or more per day is administered, divide the dose into 2 doses per day. 6) Concomitant antibiotic therapy to prevent recurrence of duodenal ulcers associated with Helicobacter pylori infection: - Dual therapy: Administer this drug 20mg and amoxicillin 750 - 1000mg together twice daily for 2 weeks. - Triple therapy: Administer this drug 40mg once daily or 20mg twice daily in combination with the following antibiotics: ① Administer clarithromycin 250mg and metronidazole 400mg twice daily for 1 week, or ② Administer amoxicillin 1g and clarithromycin 500mg twice daily for 1 week. If the treatment response is inadequate, omeprazole monotherapy may be continued. 7) Treatment of gastric or duodenal ulcers or erosions caused by nonsteroidal anti-inflammatory drugs (NSAIDs): Administer 20mg orally once daily. Most cases may heal within 4 weeks, although the healing period may vary among patients. If healing is incomplete after the initial 4 weeks of treatment, continue treatment for another 4 weeks. 8) Maintenance therapy to prevent gastric or duodenal ulcers or erosions and dyspeptic symptoms caused by NSAID use in patients on long-term NSAID therapy with a history of gastric or duodenal lesions: Administer 20mg orally once daily. 9) Prevention of recurrence of reflux esophagitis: To prevent recurrence of reflux esophagitis, administer 10mg orally once daily. * When taking this drug, swallow it whole with at least half a glass of water. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of gastroesophageal reflux and gastrointestinal disorders (e.g., ulcers and erosions); treatment of Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • heartburn
  • regurgitation
  • severe gastroesophageal reflux disease
  • peptic ulcer
  • Zollinger-Ellison syndrome
  • duodenal ulcer caused by Helicobacter pylori infection
  • gastric and duodenal ulcers or erosions caused by nonsteroidal anti-inflammatory drugs (NSAIDs)
  • dyspeptic symptoms
  • gastroesophageal reflux disease.
View approved original text

This medication is used for short-term treatment of gastric and duodenal ulcers, and also helps relieve symptoms of gastroesophageal reflux disease and gastroesophageal reflux. Additionally, it is effective for maintenance therapy of severe gastroesophageal reflux disease and peptic ulcers that do not respond well to treatment. It is utilized in treating Zollinger-Ellison syndrome and in antibiotic combination therapy to prevent recurrence of duodenal ulcers caused by Helicobacter pylori infection. It is also important in the treatment of gastric and duodenal ulcers or erosions caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and in preventing further damage in patients with a history of these conditions. Lastly, it is effective for preventing recurrence of gastroesophageal reflux disease. This drug is used for the treatment and prevention of various gastrointestinal disorders.

How to take

Adult dose

◎ Adults 1) Gastric ulcer: Administer 20mg of omeprazole orally once daily. Most ulcers may heal within 4 weeks, although the healing period may vary among patients. If healing is incomplete after the initial 4 weeks of treatment, continue treatment for another 4 weeks. In patients who have not responded to other medications, administration of 40mg once daily usually results in healing within 8 weeks, although the healing period may vary among patients. Repeat treatment if the condition recurs. 2) Short-term treatment of duodenal ulcer: Administer 20mg orally once daily. Most ulcers may heal within 2 weeks, although the healing period may vary among patients. If healing is incomplete after the initial 2 weeks of treatment, continue treatment for another 2 weeks. In patients who have not responded to other medications, administration of 40mg once daily usually results in healing within 4 weeks, although the healing period may vary among patients. Repeat treatment if the condition recurs. 3) Treatment of reflux esophagitis and symptoms of gastroesophageal reflux disease (GERD) (heartburn, regurgitation, etc.): - Reflux esophagitis: Administer 20mg orally once daily. Most cases may heal within 4 weeks, although the healing period may vary among patients. If healing is incomplete after the initial 4 weeks of treatment, continue treatment for another 4 weeks. In patients who have not responded to other medications, administration of 40mg once daily usually results in healing within 8 weeks, although the healing period may vary among patients. Repeat treatment if the condition recurs. - Treatment of symptoms of gastroesophageal reflux disease (GERD) (heartburn, regurgitation, etc.): Administer 20mg orally once daily. Treatment for 2~4 weeks is generally sufficient for healing. 4) Maintenance treatment for severe reflux esophagitis and peptic ulcers that are difficult to heal: Administer 20mg orally once daily. If the condition recurs, the dose may be increased to 40mg once daily. 5) Zollinger-Ellison syndrome: The initial dose is 60mg orally once daily. Continue treatment, adjusting the dose as appropriate for each patient. More than 90% of patients respond to doses of 20 - 120mg per day. If a dose of 80mg or more per day is administered, divide the dose into 2 doses per day. 6) Concomitant antibiotic therapy to prevent recurrence of duodenal ulcers associated with Helicobacter pylori infection: - Dual therapy: Administer this drug 20mg and amoxicillin 750 - 1000mg together twice daily for 2 weeks. - Triple therapy: Administer this drug 40mg once daily or 20mg twice daily in combination with the following antibiotics: ① Administer clarithromycin 250mg and metronidazole 400mg twice daily for 1 week, or ② Administer amoxicillin 1g and clarithromycin 500mg twice daily for 1 week. If the treatment response is inadequate, omeprazole monotherapy may be continued. 7) Treatment of gastric or duodenal ulcers or erosions caused by nonsteroidal anti-inflammatory drugs (NSAIDs): Administer 20mg orally once daily. Most cases may heal within 4 weeks, although the healing period may vary among patients. If healing is incomplete after the initial 4 weeks of treatment, continue treatment for another 4 weeks. 8) Maintenance therapy to prevent gastric or duodenal ulcers or erosions and dyspeptic symptoms caused by NSAID use in patients on long-term NSAID therapy with a history of gastric or duodenal lesions: Administer 20mg orally once daily. 9) Prevention of recurrence of reflux esophagitis: To prevent recurrence of reflux esophagitis, administer 10mg orally once daily. * When taking this drug, swallow it whole with at least half a glass of water. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should not be used in certain patients. First, it should not be administered to patients with an allergy to any ingredient in this medication. Additionally, this medication should not be used in patients with suspected malignant gastric ulcers, as it may mask malignant symptoms or delay diagnosis. It is prohibited to use this drug concurrently with the medication atazanavir, and patients taking pharmaceuticals containing rilpivirine should also refrain from using this drug. Patients with a history of myocardial infarction or those suffering from myocardial infarction should avoid this medication. Patients with liver function impairment should use this drug cautiously. This medication can remain in the body longer if liver function is impaired, so the dosage should be reduced, and particularly those with severe liver damage should not exceed a dose of 20 mg per day. Elderly patients should also use this drug carefully. When taking this medication, various side effects may occur. Neurological symptoms such as headaches, drowsiness, dizziness, and insomnia may frequently appear. Liver function abnormalities can occur, so liver enzyme levels should be checked periodically, and in severe cases, symptoms of hepatitis or liver failure may arise. It may cause kidney problems, and, rarely, nephritis leading to renal failure. In the gastrointestinal tract, symptoms such as diarrhea, constipation, nausea, vomiting, and abdominal pain are common. Severe skin reactions, such as rashes or pruritus, and in severe cases, Stevens-Johnson syndrome may occur, requiring immediate discontinuation of the medication if such symptoms develop. Allergic reactions such as angioedema or anaphylactic shock have been reported infrequently. Cardiac symptoms such as chest pain or rapid heartbeat may also appear. There may be a decrease in blood cell counts, requiring caution. Symptoms such as myalgia or arthralgia, and gynecomastia have also been reported. This medication requires periodic examination during long-term use. Special attention should be paid to patients on long-term medication (more than one year) as the risk of fractures may increase. Additionally, prolonged use may lower blood magnesium levels, necessitating magnesium supplementation and monitoring of blood levels. Caution is advised when combining this drug with certain medications like methotrexate due to an increased risk of toxicity. This medication can suppress gastric acid secretion, potentially increasing the number of bacteria in the gastrointestinal tract, thereby slightly raising the risk of diarrhea caused by Clostridium difficile. If diarrhea persists, it should be reported to a physician. Pregnant women should carefully consider the risks to the fetus when using this medication, and nursing mothers are advised to discontinue breastfeeding while taking this medication. The safety of this drug in children has not been adequately established, so it is preferable not to use it in pediatrics. In the event of overdose, symptoms such as vomiting, diarrhea, headaches, dizziness may occur, and in severe cases, mental confusion may arise, though these effects are generally temporary. This medication should be kept out of reach of children and should not be transferred to other containers, but rather stored in the original container. After use, the lid of the container should be tightly closed.

Side effects

Headache, drowsiness, dizziness, insomnia, sensory disturbances, feelings of faintness, vertigo, confusion, agitation, aggression, hallucinations, depression, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, interstitial nephritis, diarrhea, melena, constipation, nausea, vomiting, abdominal pain, abdominal bloating, dry mouth, stomatitis, gastrointestinal candidiasis, erythema, rash, urticaria, itching, dermatitis, vesicular rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, photosensitivity, alopecia, angioedema, fever, bronchospasm, interstitial nephritis, anaphylactic shock, chest pain, tachycardia, bradycardia, palpitations, leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, back pain, arthralgia, muscle weakness, myalgia, gynecomastia, cough, asthenia, malaise, peripheral edema, increased sweating, visual disturbances, vision impairment, taste disorders, breast pain, breast lump, hyponatremia, erectile dysfunction, Clostridium difficile-associated diarrhea, hypomagnesemia, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, systemic lupus erythematosus, discoid lupus erythematosus, gastric polyp, hypocalcemia, hypokalemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. Also, it is advisable to store it at room temperature that is neither excessively hot nor cold.

Appearance and packaging

Appearance

A hard capsule with an upper red-brown and a lower pink color filled with white to light brown enteric-coated granules.

Package unit

30 capsules/bottle, 100 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.